BioCentury | Apr 9, 2021
Deals

April 8 Quick Takes: Hologic buying Mobidiag for nearly $800M; plus Biogen-Bio-Thera, Dicerna royalty sale, a SPAC for LumiraDx, Cidara-Janssen and Chi-Med’s $100M

...Baring Private Equity Asia at $30.50 per ADS. BC Staff Hologic Inc. Mobidiag Ltd. Dicerna Pharmaceuticals Inc. Biogen Inc. Bio-Thera Solutions Ltd. Hutchison China MediTech Ltd. LumiraDx...
BioCentury | Feb 5, 2021
Emerging Company Profile

Deals with Allogene, ADC reflect Overland’s ambition to tap parent Hillhouse’s network to bring innovation to China

...partnership. He is also an alum of Hutchison China MediTech Ltd....
BioCentury | Jan 12, 2021
Deals

Jan. 11 Quick Takes: Inmagene gains options to four Chi-Med immunology programs; plus Zai-Turning Point, Mirati-Resolution, GSK-Eligo, Biogen-Apple, Adaptive-AZ and more

...sclerosis complex tumor suppressor 1TSC2 – Tuberous sclerosis complex tumor suppressor 2 BC Staff Inmagene Biopharmaceuticals Co. Ltd. Hutchison China MediTech Ltd. Mirati...
BioCentury | Dec 31, 2020
Regulation

Dec. 30 Quick Takes: A first for Chi-Med; plus Orphazyme, BMS, FDA REMS, Pfizer, Astellas, Alkermes, Osmotica, Quanterix, Ampio and Novartis

...Staff Chi-Med’s surufatinib approved in ChinaChina’s National Medical Products Administration (NMPA) approved an NDA from Hutchison China MediTech Ltd....
...Heat shock protein 70 MTM1 – Myotubularin 1 BC Staff surufatinib, sulfatinib (HMPL-012) Ontinua ER, arbaclofen (OS-440, Arbaclofen ER) Quanterix Corp. Hutchison China MediTech Ltd. U.S...
BioCentury | Dec 15, 2020
Deals

Hillhouse’s Overland builds momentum with second marquee China deal with Allogene

...partnership. He is also an alum of Hutchison China MediTech Ltd....
BioCentury | Dec 15, 2020
Deals

ADC Therapeutics caps year of milestones by building bridge to China via Hillhouse-backed Overland’s debut deal

...partnership. He is also an alum of Hutchison China MediTech Ltd....
BioCentury | Nov 19, 2020
Finance

Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more

...Tube gastric cancer test by YE20.TARGETSBDKRB2 (BR2) – Bradykinin B2 receptor BC Staff Emergex Vaccines Holdings Ltd. Triastek Inc. Hutchison China MediTech Ltd. Kodiak...
BioCentury | Nov 18, 2020
Product Development

Annual BayHelix awards highlight China’s growing life sciences sector; HKEX’s Li, Zai’s Du, Innovent among winners

...one of the first women biotech CEOs in China, previously served as CEO of the Hutchison China MediTech Ltd....
BioCentury | Nov 14, 2020
Deals

Innovation in a hurry: China biotechs see a fast track to global stage – survey

...the global market,” said Christian Hogg, CEO of Hutchison China MediTech Ltd....
...1VEGF – Vascular endothelial growth factor C. Simone Fishburn Hutchison China MediTech Ltd. Sofinnova...
BioCentury | Oct 7, 2020
Finance

With life sciences now a ‘core’ investment area, General Atlantic picks a global head

...WuXi PharmaTech Inc.More recently, it has funded biotechs including Immunocore Ltd., Canbridge Pharmaceuticals Inc. and Hutchison China MediTech Ltd....
Items per page:
1 - 10 of 180
BioCentury | Apr 9, 2021
Deals

April 8 Quick Takes: Hologic buying Mobidiag for nearly $800M; plus Biogen-Bio-Thera, Dicerna royalty sale, a SPAC for LumiraDx, Cidara-Janssen and Chi-Med’s $100M

...Baring Private Equity Asia at $30.50 per ADS. BC Staff Hologic Inc. Mobidiag Ltd. Dicerna Pharmaceuticals Inc. Biogen Inc. Bio-Thera Solutions Ltd. Hutchison China MediTech Ltd. LumiraDx...
BioCentury | Feb 5, 2021
Emerging Company Profile

Deals with Allogene, ADC reflect Overland’s ambition to tap parent Hillhouse’s network to bring innovation to China

...partnership. He is also an alum of Hutchison China MediTech Ltd....
BioCentury | Jan 12, 2021
Deals

Jan. 11 Quick Takes: Inmagene gains options to four Chi-Med immunology programs; plus Zai-Turning Point, Mirati-Resolution, GSK-Eligo, Biogen-Apple, Adaptive-AZ and more

...sclerosis complex tumor suppressor 1TSC2 – Tuberous sclerosis complex tumor suppressor 2 BC Staff Inmagene Biopharmaceuticals Co. Ltd. Hutchison China MediTech Ltd. Mirati...
BioCentury | Dec 31, 2020
Regulation

Dec. 30 Quick Takes: A first for Chi-Med; plus Orphazyme, BMS, FDA REMS, Pfizer, Astellas, Alkermes, Osmotica, Quanterix, Ampio and Novartis

...Staff Chi-Med’s surufatinib approved in ChinaChina’s National Medical Products Administration (NMPA) approved an NDA from Hutchison China MediTech Ltd....
...Heat shock protein 70 MTM1 – Myotubularin 1 BC Staff surufatinib, sulfatinib (HMPL-012) Ontinua ER, arbaclofen (OS-440, Arbaclofen ER) Quanterix Corp. Hutchison China MediTech Ltd. U.S...
BioCentury | Dec 15, 2020
Deals

Hillhouse’s Overland builds momentum with second marquee China deal with Allogene

...partnership. He is also an alum of Hutchison China MediTech Ltd....
BioCentury | Dec 15, 2020
Deals

ADC Therapeutics caps year of milestones by building bridge to China via Hillhouse-backed Overland’s debut deal

...partnership. He is also an alum of Hutchison China MediTech Ltd....
BioCentury | Nov 19, 2020
Finance

Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more

...Tube gastric cancer test by YE20.TARGETSBDKRB2 (BR2) – Bradykinin B2 receptor BC Staff Emergex Vaccines Holdings Ltd. Triastek Inc. Hutchison China MediTech Ltd. Kodiak...
BioCentury | Nov 18, 2020
Product Development

Annual BayHelix awards highlight China’s growing life sciences sector; HKEX’s Li, Zai’s Du, Innovent among winners

...one of the first women biotech CEOs in China, previously served as CEO of the Hutchison China MediTech Ltd....
BioCentury | Nov 14, 2020
Deals

Innovation in a hurry: China biotechs see a fast track to global stage – survey

...the global market,” said Christian Hogg, CEO of Hutchison China MediTech Ltd....
...1VEGF – Vascular endothelial growth factor C. Simone Fishburn Hutchison China MediTech Ltd. Sofinnova...
BioCentury | Oct 7, 2020
Finance

With life sciences now a ‘core’ investment area, General Atlantic picks a global head

...WuXi PharmaTech Inc.More recently, it has funded biotechs including Immunocore Ltd., Canbridge Pharmaceuticals Inc. and Hutchison China MediTech Ltd....
Items per page:
1 - 10 of 180